Last reviewed: June 18, 2026

Last updated: June 18, 2026

Written by: Jay Hastings, CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

Once weekly. The Ozempic prescribing information specifies administration once weekly, at any time of day, with or without meals, and the weekly cadence is the only frequency the label describes. What changes over time is the dosage, not the frequency: the schedule starts at 0.25 mg once weekly, increases to 0.5 mg after four weeks, and permits further increases to 1 mg and then 2 mg after at least four weeks on each dose if additional glycemic control is needed. Under those labeled minimums, reaching the highest dosage takes at least twelve weeks — not sixteen, and not a fixed schedule that applies to everyone.

Why Weekly Is Possible at All

Weekly dosing is a consequence of molecular design. Semaglutide is a peptide of molecular weight 4,113.58 g/mol whose main protraction mechanism is albumin binding, achieved by modifying position 26 with a hydrophilic spacer and a C18 fatty di-acid. It is further modified at position 8 to resist degradation by dipeptidyl-peptidase 4.

The result is extensive plasma albumin binding — greater than 99 percent — which reduces renal clearance and protects the peptide from degradation, producing an elimination half-life of approximately one week. Native GLP-1 is cleared in minutes. The engineering is what converts a peptide that would need continuous infusion into one dosed once a week.

The Dosage Schedule, Stated Precisely

The labeled schedule is: start at 0.25 mg once weekly; after four weeks increase to 0.5 mg once weekly; if additional glycemic control is needed, increase to 1 mg once weekly after at least four weeks on 0.5 mg; and if additional glycemic control is needed, increase to 2 mg once weekly after at least four weeks on 1 mg. For the kidney indication, the label directs increasing to 1 mg once weekly after at least four weeks on 0.5 mg.

Two features of that language deserve attention. "At least" sets minimum intervals, not fixed ones. And each increase is conditional on additional glycemic control being needed — meaning the schedule is not an escalator everyone rides to the top. Where you settle is a clinical judgment your prescriber makes.

Why the Intervals Are Four Weeks

The four-week interval matches the pharmacokinetics. With a one-week half-life, concentrations at any given dose level approach steady state after roughly four to five half-lives. Increasing before that point means titrating against an incomplete picture of both efficacy and tolerability.

It also matches the tolerability curve. Nausea, vomiting, diarrhea, abdominal pain, and constipation were the most common adverse reactions reported in at least five percent of Ozempic-treated patients, and these cluster during escalation. Longer intervals give the gastrointestinal tract time to accommodate.

Changing Your Weekly Day

The label permits changing the day of weekly administration if necessary, as long as the time between two doses is at least two days — stated as more than 48 hours. That constraint prevents doses from stacking before the previous one has substantially cleared.

Tirzepatide labeling sets a different minimum, at least three days or 72 hours. The two molecules are not interchangeable on scheduling any more than they are on strength, and applying one label's interval to the other product is an error worth avoiding.

If a Dose Is Missed

The label contains a specific provision for missed doses, with a defined window and defined conditions depending on how much time has passed. It is deliberately conditional, and the right answer for you depends on where you are in your regimen.

That is why this article will not restate it as advice. Read the Instructions for Use dispensed with your product, and call the prescribing clinician or your pharmacist. Both can give you an answer specific to your dose and your timing in less time than it takes to search for a general rule.

Frequency Is Not the Same as Duration

Weekly is how often. How long is a separate question, and the trial evidence answers it clearly. The label's cardiovascular and kidney outcome data are plotted over years, with the kidney analysis describing observed follow-up to week 104 and the cardiovascular figure truncated at 52 months.

Ozempic is indicated for chronic conditions — glycemic control, cardiovascular risk reduction, and kidney outcomes in adults with type 2 diabetes. It is not a course of treatment with an endpoint you reach and stop. Discontinuation is a clinical decision, not a milestone.

What Frequency Does Not Change

Because it is dosed weekly rather than daily, there is a temptation to treat Ozempic as low-maintenance. The label's other instructions still apply continuously: tell healthcare providers about planned surgeries or procedures because of reported pulmonary aspiration during general anesthesia or deep sedation; discontinue in women at least two months before a planned pregnancy because of semaglutide's long washout period; and use caution with concomitant oral medications, whose absorption may be affected by delayed gastric emptying.

Once weekly describes the injection. It does not describe how often the medication is acting, which is continuously.

How Your Genetics Relate to GLP-1 Pathways

Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, FTO rs9939609, and MC4R rs17782313 — relate to the biological pathways these medications act on. These are pathway-level associations only and do not predict how much weight you will lose or how you will respond to any specific medication. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights so you and your provider can see how your genes relate to these pathways. It does not recommend, prescribe, or determine which medication, dose, or peptide is right for you. The PlexusDx Precision Peptide Genetic Test ($298) gives you and your provider pathway-level genetic context to support a more personalized conversation. Genetics is a guide, not a guarantee.

Access Personalized GLP-1 Care Through PlexusDx

PlexusDx offers seven prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Semaglutide Injection is $189/mo month-to-month, or from $149/mo on the 6-month plan. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test ($298) to personalize your protocol from day one.

Frequently Asked Questions

How often do you take Ozempic?

Once weekly. The prescribing information specifies administration once weekly, at any time of day, with or without meals, injected subcutaneously in the abdomen, thigh, or upper arm. Weekly is the only frequency the label describes. What changes over the course of treatment is the dosage, not the frequency, and dosage changes follow a labeled escalation schedule.

How long does it take to reach the highest Ozempic dose?

Under the labeled minimums, at least twelve weeks. The schedule starts at 0.25 mg once weekly, increases to 0.5 mg after four weeks, then to 1 mg after at least four weeks on 0.5 mg, then to 2 mg after at least four weeks on 1 mg — with each increase conditional on additional glycemic control being needed. Not everyone progresses to the highest dosage.

Why is Ozempic dosed weekly rather than daily?

Because of how the molecule is engineered. Semaglutide is modified with a hydrophilic spacer and a C18 fatty di-acid that drive albumin binding above 99 percent, reducing renal clearance and protecting it from degradation, and further modified to resist dipeptidyl-peptidase 4. The result is an elimination half-life of approximately one week, compared with minutes for native GLP-1.

Can I change which day I inject?

The label permits changing the day of weekly administration if necessary, as long as at least two days — more than 48 hours — separate two doses, which prevents doses from stacking. Note that tirzepatide products use a different minimum of at least three days, or 72 hours, so the two labels should not be applied interchangeably. Confirm any change with your prescriber.

What if I miss a weekly dose?

The label contains a specific provision with a defined window and conditions that depend on how much time has elapsed. Because the correct answer varies with your regimen and your timing, it belongs to the Instructions for Use dispensed with your product and to your prescriber or pharmacist rather than to a general article. Either can give you a specific answer quickly.

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.

Real prescribers. Published prices. No surprises.

Licensed providers in all 50 states. Online intake. No insurance, no membership required.

Start My Intake

~60 seconds · $0 charged until your provider approves